| ALCON AG NAM. SF -,04 |
| Schweiz |
| Gesundheit |
| CH0432492467 / A2PDXE |
| 2U3 (Frankfurt) / ALC (NYSE) |
| FRA:2U3, ETR:2U3, 2U3:GR, NYSE:ALC |
| SMI |
| https://www.alcon.com/ |
|
Alcon Inc. is a global eye care company focused on products and technologies that support vision health across surgical and everyday care settings. Alcon Inc. develops, manufactures, and markets a broad portfolio for cataract surgery, vitreoretinal p..
>Volltext.. |
| 34725.72 Mio. EUR |
| 38110.91 Mio. EUR |
| 9567.85 Mio. EUR |
| 2173.06 Mio. EUR |
| 567.68 Mio. EUR |
| 1.16 EUR |
| 4746.69 Mio. EUR |
| 1213.77 Mio. EUR |
| 2013.78 Mio. EUR |
| 0.46 |
| 0.36% |
| -44.78% |
| 0.31 EUR |
| 0.44% |
| 0.44% |
| 05.05.26 - 0.3059€ 10.05.23 - 0.22703099€ >weitere anzeigen... |
| - |
| ALCON |
| 11.11.26 |
|